Takeda and Lundbeck’s Trintellix approved in Japan for depression
Takeda has announced that its drug Trintellix (vortioxetine) has been approved by the Japanese Ministry...
Read More...
Focus:
Asia-pacific
-
![]()
Andhra Pradesh and Telangana: Indian contract manufacturing powerhouses for US API supply
In line with the global perception of a strong generics manufacturing industry in India, the...
Read More...
-
![AstraZeneca revises Linzess deal with Ironwood Pharmaceuticals]()
AstraZeneca revises Linzess deal with Ironwood Pharmaceuticals
AstraZeneca has revised its agreement with Ironwood Pharmaceuticals for irritable bowel syndrome with constipation (IBS-C)...
Read More...
-
![US FDA partners Australia and Canada for cancer therapies review]()
US FDA partners Australia and Canada for cancer therapies review
The US Food and Drug Administration (FDA) has partnered with the Australian Therapeutic Goods Administration...
Read More...
-
![]()
Biogen and Eisai discontinue Alzheimer’s trials of BACE inhibitor
Biogen and Eisai have discontinued the clinical development programme of beta amyloid cleaving enzyme (BACE)...
Read More...
-
![Sumitomo Dainippon and Roivant form $3bn alliance]()
Sumitomo Dainippon and Roivant form $3bn alliance
Japan-based Sumitomo Dainippon Pharma has signed a memorandum of understanding (MoU) with healthcare technology company...
Read More...
-
![Boehringer Lupin agreement]()
Boehringer licences Lupin’s cancer asset in $720m deal
Germany-based Boehringer Ingelheim has entered into a licensing, development and commercialisation agreement worth more than...
Read More...
-
![]()
AstraZeneca receives approval to market cancer drug Tagrisso in China
British pharmaceutical firm AstraZeneca has received regulatory approval in China to market Tagrisso as a...
Read More...
-
![Insilico Medicine develops new AI drug discovery system]()
Insilico Medicine develops new AI drug discovery system
Insilico Medicine has developed an artificial intelligence (AI)-powered system to facilitate the creation of therapeutic...
Read More...
-
![Diabetes treatment]()
Glenmark wins regulatory approval to market diabetes drug in India
Glenmark Pharmaceuticals has achieved regulatory approval in India for its novel type 2 diabetes (T2D)...
Read More...
